What Challenges Does Inter Tumor Heterogeneity Present?
One of the main challenges posed by inter tumor heterogeneity is the difficulty in developing universally effective treatments. This diversity can lead to variability in clinical trial results and complicate the process of identifying reliable biomarkers for prognosis and treatment response. Additionally, the complexity and cost of comprehensive molecular profiling can be a barrier to widespread implementation in clinical practice.
